sipatrigine has been researched along with Brain Ischemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meldrum, BS; Smith, SE | 1 |
| Lekieffre, D; Meldrum, BS; Smith, SE; Sowinski, P | 1 |
| Sharp, FR; Swanson, RA | 1 |
| Chen, J; Graham, SH; Lan, J; Leach, MJ; Simon, RP | 1 |
| Dopson, M; Eisenthal, D; Leach, MJ; Nobbs, M; Swan, JH | 1 |
| Bullock, R; Harms, JF; Tsuchida, E; Woodward, JJ | 1 |
| Gray, JA; Hodges, H; Leach, MJ; Man, CM; Meldrum, BS; Sinden, JD; Smith, SE; Sowinski, P | 1 |
| Alp, MS; Aspey, BS; Harrison, MJ; Patel, Y | 1 |
1 review(s) available for sipatrigine and Brain Ischemia
| Article | Year |
|---|---|
Effects of combined glutamate and platelet-activating factor inhibition on the outcome of focal cerebral ischaemia - an initial screening study.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Drug Combinations; Glutamic Acid; Leucine; Male; Movement Disorders; Neuroprotective Agents; Periaqueductal Gray; Piperazines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sodium Channel Blockers; Time Factors | 1997 |
7 other study(ies) available for sipatrigine and Brain Ischemia
| Article | Year |
|---|---|
Cerebroprotective effect of lamotrigine after focal ischemia in rats.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Drug Administration Schedule; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Lamotrigine; Male; Piperazines; Pyrimidines; Rats; Rats, Inbred F344; Sodium Channels; Triazines | 1995 |
Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat.
Topics: Animals; Brain Ischemia; Carotid Artery, Common; Cerebral Arteries; Cerebral Infarction; Female; Glutamates; Glutamic Acid; Hippocampus; Male; Neurotransmitter Uptake Inhibitors; Piperazines; Pyrimidines; Rats; Rats, Inbred F344 | 1993 |
BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.
Topics: Brain Ischemia; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Piperazines; Pyrimidines | 1994 |
Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
Topics: Animals; Brain; Brain Ischemia; Glutamates; Glutamic Acid; Ion Channel Gating; Male; Neurotransmitter Uptake Inhibitors; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers | 1994 |
BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.
Topics: Acetylcholine; Amino Acids; Animals; Blood Pressure; Brain Injuries; Brain Ischemia; Cerebral Cortex; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Heart Rate; Male; Neurotransmitter Agents; Organ Culture Techniques; Piperazines; Pyrimidines; Rats; Rats, Inbred F344; Rats, Wistar; Veratrine | 1993 |
A use-dependent sodium channel antagonist, 619C89, in reduction of ischemic brain damage and glutamate release after acute subdural hematoma in the rat.
Topics: Animals; Aspartic Acid; Brain Ischemia; Dialysis; Disease Models, Animal; Glutamic Acid; Hematoma, Subdural; Male; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Threonine | 1996 |
Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat.
Topics: Animals; Arterial Occlusive Diseases; Behavior, Animal; Brain Ischemia; Cerebral Arteries; Cerebral Cortex; Cognition Disorders; Dose-Response Relationship, Drug; Male; Maze Learning; Motor Activity; Nervous System Diseases; Neurologic Examination; Neuroprotective Agents; Piperazines; Pyrimidines; Rats; Rats, Inbred F344; Sodium Channel Blockers; Time Factors | 1997 |